Company Search:
Advanced Search
Sponsored Links
Shield Therapeutics PLC Company Snapshot
Shield Therapeutics PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shield Therapeutics PLC with three other companies in this sector in the United Kingdom: Gunsynd PLC (2017 sales of £825,000.00 [US$1.06 million] ), Realm Therapeutics PLC (£860,861.16 [US$1.11 million] of which 100% was Drug Development and WC), and Provexis PLC (£227,618.00 [US$292,193.23 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shield Therapeutics PLC
  Stock Performance Chart for Shield Therapeutics PLC
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 50.50p
(Figures in Pounds Sterling)
1 Week -7.3%   13 Weeks 38.7%  
4 Weeks 49.4%   52 Weeks 77.2%  
Shield Therapeutics PLC Key Data:
  Ticker: STX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 637,000
(Year Ending Jan 2018).
Employees: 47
  Currency: Pounds Sterling Market Cap: 58,795,130
  Fiscal Yr Ends: December Shares Outstanding: 116,426,000
  Share Type: Ordinary Closely Held Shares: 93,754,993
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.